(S)-Pyrrolidin-2-ylmethanamine dihydrochloride
97%
- Product Code: 113850
CAS:
103382-84-9
| Molecular Weight: | 173.08 g./mol | Molecular Formula: | C₅H₁₄Cl₂N₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD11974898 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature, dry and sealed |
Product Description:
Used primarily in pharmaceutical research, this compound serves as a key intermediate in the synthesis of various bioactive molecules. It is particularly valuable in the development of drugs targeting neurological disorders, such as Alzheimer's disease and Parkinson's disease, due to its structural compatibility with neurotransmitter systems. Additionally, it plays a role in the creation of chiral catalysts, which are essential in asymmetric synthesis for producing enantiomerically pure compounds. Its application extends to the field of medicinal chemistry, where it aids in the design of novel therapeutic agents with improved efficacy and selectivity.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | Solid |
| Purity (%) | 96.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | ฿2,510.00 |
+
-
|
| 1.000 | 10-20 days | ฿5,630.00 |
+
-
|
| 5.000 | 10-20 days | ฿24,030.00 |
+
-
|
(S)-Pyrrolidin-2-ylmethanamine dihydrochloride
Used primarily in pharmaceutical research, this compound serves as a key intermediate in the synthesis of various bioactive molecules. It is particularly valuable in the development of drugs targeting neurological disorders, such as Alzheimer's disease and Parkinson's disease, due to its structural compatibility with neurotransmitter systems. Additionally, it plays a role in the creation of chiral catalysts, which are essential in asymmetric synthesis for producing enantiomerically pure compounds. Its application extends to the field of medicinal chemistry, where it aids in the design of novel therapeutic agents with improved efficacy and selectivity.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :